8-K: Northrop Grumman Reports Record Backlog Despite B-21 Program Charge
Quarterly Report
Northrop Grumman's Q4 results show a 6% sales increase and a record backlog of $84.2 billion, but were impacted by a $1.56 billion pre-tax charge related to the B-21 program.
Summary
- Northrop Grumman reported a 6% increase in fourth-quarter sales, reaching $10.6 billion, and a 7% increase in full-year sales to $39.3 billion.
- The company's total backlog reached a record $84.2 billion, driven by a full-year book-to-bill ratio of 1.14.
- A significant pre-tax charge of $1.56 billion was recorded due to the low-rate initial production (LRIP) phase of the B-21 program.
- Full-year 2023 diluted earnings per share (EPS) were $13.53, which includes a $7.68 per share impact from the B-21 charge and a $2.08 per share impact from mark-to-market (MTM) expenses.
- Operating cash flow for 2023 was $3.9 billion, with an adjusted free cash flow of $2.1 billion.
- The company has provided a strong 2024 sales and margin guidance, consistent with previous outlooks.
- Northrop Grumman reaffirmed its 2024 and 2025 free cash flow outlook and projects solid growth in 2026 with a greater than 15% CAGR.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative due to the significant B-21 charge impacting earnings, despite strong sales and backlog. The future outlook is positive, but the current results are mixed.
Positives
- The company achieved a record backlog of $84.2 billion, indicating strong future demand.
- Sales increased by 6% in the fourth quarter and 7% for the full year, demonstrating solid growth.
- The company generated free cash flow at the high end of its guidance range for 2023.
- Northrop Grumman reaffirmed its free cash flow outlook for 2024 and 2025.
- The company projects strong free cash flow growth through 2026 with a greater than 15% CAGR.
- The company's 2024 guidance reflects continued strong sales and earnings growth.
Negatives
- A significant $1.56 billion pre-tax charge was recorded due to the B-21 program's LRIP phase.
- The B-21 charge negatively impacted the company's net earnings and EPS for both the quarter and the full year.
- The company experienced a net loss of $535 million in the fourth quarter of 2023.
- Full-year net earnings decreased by 58% to $2.1 billion.
- The operating margin rate decreased to (3.7)% in the fourth quarter and 6.5% for the full year.
Risks
- The B-21 program's LRIP phase is expected to be performed at a loss due to macroeconomic factors and higher manufacturing costs.
- The company is exposed to risks related to global macroeconomic, security, and political environments, including inflationary pressures and supply chain challenges.
- Changes in government budgets, appropriations, and procurement priorities could impact the company's performance.
- The company's financial guidance does not account for potential extended continuing resolutions or government shutdowns.
- The company faces risks related to contract cost growth and the accuracy of its estimates.
- The company is exposed to cyber and other security threats.
Future Outlook
Northrop Grumman anticipates continued strong sales and earnings growth in 2024, with free cash flow expected to grow at a greater than 15% CAGR through 2026. The company has provided 2024 sales guidance of $40.8 to $41.2 billion and free cash flow guidance of $2.25 to $2.65 billion.
Management Comments
- Kathy Warden, chair, chief executive officer and president, stated that the team delivered a strong finish to the year in 2023.
- She also noted that the company generated free cash flow at the high end of its guidance range and significantly exceeded sales guidance.
- Warden mentioned that the company beat EPS consensus absent the B-21 charge.
- She highlighted that the 2024 guidance reflects continued strong sales and earnings growth due to sustained global demand.
- Warden also stated that the company is reaffirming its cash flow outlook for 2024 and 2025, with free cash flow expected to grow at a greater than 15 percent CAGR through 2026.
Industry Context
This announcement comes amid a period of increased global demand for defense products and services. Northrop Grumman's strong backlog and sales growth reflect this trend. However, the B-21 program charge highlights the risks and challenges associated with large, complex defense contracts, particularly in the current macroeconomic environment.
Comparison to Industry Standards
- Lockheed Martin, a major competitor, also reported strong sales growth in its recent results, indicating a general trend of increased demand in the defense sector.
- However, Lockheed Martin did not report a similar large charge related to a specific program, suggesting that Northrop Grumman's B-21 program faces unique challenges.
- Raytheon Technologies, another competitor, has also seen increased demand for its products, but its financial performance has been more stable than Northrop Grumman's due to the B-21 charge.
- Boeing's defense division has faced challenges with some of its fixed-price development programs, similar to Northrop Grumman's B-21 program, highlighting the risks of these types of contracts.
- The book-to-bill ratio of 1.14 for Northrop Grumman is a positive sign, indicating that the company is securing more new orders than it is fulfilling, which is a key metric for defense contractors.
Stakeholder Impact
- Shareholders will be impacted by the lower earnings and EPS due to the B-21 charge.
- Employees may be affected by the company's efforts to manage costs and improve efficiency.
- Customers will continue to receive products and services, with a focus on meeting their needs.
- Suppliers may be impacted by the company's efforts to negotiate better terms and manage costs.
- Creditors will be impacted by the company's financial performance and cash flow.
Next Steps
- The company will continue to execute on its existing contracts and pursue new business opportunities.
- Northrop Grumman will focus on managing the B-21 program and mitigating the impact of macroeconomic factors.
- The company will continue to monitor the global macroeconomic, security, and political environments.
- Northrop Grumman will webcast its earnings conference call at 9:00 a.m. Eastern Time on January 25, 2024.
Key Dates
| Date | Description |
|---|---|
| 2015 | The U.S. Air Force awarded Northrop Grumman the B-21 contract. |
| January 25, 2024 | Northrop Grumman issued an earnings release announcing its financial results for the quarter and year ended December 31, 2023. |
Keywords
Northrop Grumman, B-21, backlog, defense, aerospace, earnings, free cash flow, sales, LRIP, EPS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.